Related Experiment Video
Updated: Jul 25, 2026
Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Using a mammalian cell cycle simulation to interpret differential kinase inhibition in anti-tumour pharmaceutical
C Chassagnole1, R C Jackson, N Hussain
1Physiomics plc, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK. cchassagnole@physiomics-plc.com
Abstract:
Systems biology needs to show practical relevance to commercial biological challenges such as those of pharmaceutical development. The aim of this work is to design and validate some applications in anti-cancer therapeutic development. The test system was a group of novel cyclin-dependent kinase (CDK) inhibitors synthesised by Cyclacel Ltd. The measured in vitro IC50s of each compound were used as input data to a proprietary cell cycle model developed by Physiomics plc. The model was able to predict over three orders of magnitude the cytotoxicity of each compound without model adaptation to specific cancer cell types. This pattern matched the experimentally determined data. One class of compounds was predicted to cause an increase of the cell cycle length with a non-linear dose-response curve. Further work will use apoptosis and DNA replication simulations to look at overall cell effects.
Insights
Systems biology models can predict anti-cancer drug efficacy. A cell cycle model accurately predicted the cytotoxicity of novel cyclin-dependent kinase (CDK) inhibitors across various cancer types.
Area of Science:
- Systems biology
- Pharmacology
- Computational biology
Background:
- Systems biology requires practical applications in pharmaceutical development.
- Anti-cancer drug discovery faces commercial challenges.
Purpose of the Study:
- To design and validate systems biology applications for anti-cancer therapeutic development.
- To assess the predictive power of a cell cycle model for drug cytotoxicity.
Main Methods:
- Utilized novel cyclin-dependent kinase (CDK) inhibitors synthesized by Cyclacel Ltd.
- Employed a proprietary cell cycle model from Physiomics plc.
- Input in vitro IC50 data into the cell cycle model.
Main Results:
- The cell cycle model accurately predicted compound cytotoxicity across three orders of magnitude.
- Predictions showed strong correlation with experimentally determined data.
- One compound class was predicted to increase cell cycle length non-linearly.
Conclusions:
- Systems biology models can effectively predict drug responses in anti-cancer development.
- The validated cell cycle model demonstrates broad applicability across cancer types.
- Further simulations will explore apoptosis and DNA replication for comprehensive cell effect analysis.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
